News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Udhayvir Grewal: Poorly differentiated GEP carcinomas should be treated as adenocarcinomas
Udhayvir Grewal/X
Mar 12, 2025, 16:41

Udhayvir Grewal: Poorly differentiated GEP carcinomas should be treated as adenocarcinomas

Udhayvir Grewal, Resident Physician at Ochsner LSU Health Shreveport Academy Medical Centre, shared a post on X:

“Every poorly differentiated gastroenteropancreatic carcinoma with neuroendocrine differentiation should be treated like an adenocarcinoma, no matter how strong the neuroendocrine differentiation is.

Neuroendocrine differentiation is typically a poor prognostic sign. Carbo etop has little to no activity.”

More posts featuring Udhayvir Grewal.

adenocarcinomas cancer gastroenteropancreatic carcinoma GEP carcinomas neuroendocrine differentiation OncoDaily Oncology Udhayvir Grewal
Special Coverage
Science
Aug 8, 2025, 13:26
Kamlesh Khunti: GLP-1 and SGLT2 in T2D - Discontinuation, Reinitiation and Switching Swedish registry data
Blog
Aug 8, 2025, 13:14
Claudia Villa Celi: The Other Side of Fellowship
Career
Aug 8, 2025, 13:14
Nicholas Navin: The Future of Cancer Research
Science
Aug 8, 2025, 13:11
Scott Kopetz: A Promising Strategy for KRASi Resistance
Blog
Aug 8, 2025, 13:00
Matt Dun: The First Therapeutic Step Forward for H3K27-Altered Diffuse Midline Glioma
Blog
Aug 8, 2025, 13:00
Sumanta K. Pal Supports Petros Grivas' "Obliteride" Campaign to Cure Bladder Cance
Science
Aug 8, 2025, 12:39
Yan Leyfman: Analyzing Demographic Trends in NCI-Sponsored Early-Phase Cancer Clinical Trials
Insight
Aug 8, 2025, 12:19
Yazan Madanat Presented KOMET-007 Results at the 4th Translational Summit on Heme Malignancies
Blog
Aug 8, 2025, 12:08
Jia (Jenny) Liu: Strategies to Operationalize Wellbeing at an Individual Level at MOGA25
Positive
Aug 8, 2025, 12:06
Prasanna Alluri Received a $3.1 Million R01 Grant from the NCI - UTSW Radiation Oncology
Science
Aug 8, 2025, 12:00
Raffaele Colombo: Is There a Synergistic Effect Between Enfortumab Vedotin and Pembrolizumab?
Career
Aug 8, 2025, 11:58
Harout Semerjian: A Visionary Leader Steering Geron Toward a New Era in Oncology